Infection prevention is often discussed in terms of chemistry, performance data and laboratory standards. Yet in practice, the success of any cleaner and disinfectant is determined by something far more straightforward: whether it can be used consistently, correctly and with ease in real clinical environments.
That distinction is increasingly important as new disinfectant products continue to enter the market, particularly those based on Peracetic Acid (PAA). While many demonstrate strong performance in controlled testing, the operational reality in healthcare settings is less forgiving. Products must perform reliably in use, not just under ideal conditions.
For more than 16 years, DiffX™ has been used across NHS and healthcare environments with that principle in mind.
Designed for real-world healthcare environments
Healthcare settings place continuous pressure on infection prevention processes.
Ease of use, consistency in application, and integration into existing workflows are becoming central to product evaluation, alongside traditional performance metrics.
Staff require products that fit into how they already work without adding unnecessary complexity or steps.
“At MTP Innovations, we’ve always focused on how products perform in practice, not just in theory,” says Mike Jepson, Managing Director, MTP Innovations. “Healthcare teams need solutions that are straightforward, consistent, and dependable under real-world conditions.”
Simplifying preparation and practicality as a deciding factor
As the range of cleaning and disinfectant products available to healthcare providers continues to evolve, decision-making is increasingly influenced by practical considerations alongside efficacy data.
A key feature of DiffX™ is its dissolvable sachet system, designed to simplify preparation and improve consistency of use. The sachets dissolve directly on contact with warm water, supporting accurate dilution and reducing the need for additional handling steps.
In operational terms, this reduces variability between users and settings, helping ensure the product is prepared correctly every time it is used.
“Infection prevention only works when it is applied consistently,” says Mike. “Reducing unnecessary complexity helps support that consistency across busy teams and high-turnover environments.”
DiffX™ is designed to maintain stable efficacy for 24 hours when prepared according to instructions. This provides a level of operational certainty that supports routine cleaning schedules and reduces the need for frequent re-preparation.
Long-term use in clinical settings
As the original PAA disinfectant sachet formula introduced into the NHS, DiffX™ has been in use for more than 16 years. Its continued adoption reflects not only its efficacy profile but also its suitability for routine, large-scale clinical use.
Alongside this, MTP Innovations maintains a direct, founder-led support model, giving healthcare organisations access to senior technical and commercial expertise without layers of sales reps.
“Our customers value being able to speak directly to people who understand both the product and the operational challenges they face,” says Mike. “That relationship has always been central to how we work.”
For more information on DiffX™, you can contact Mike by emailing mike.jepson@mtpinnovations.com.
